Literature DB >> 27365211

Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer.

Kathleen D Lyons1, Hsin H Li2, Emily M Mader2, Telisa M Stewart2, Christopher P Morley2, Margaret K Formica2, Scott D Perrapato3, John D Seigne1, Elias S Hyams1, Brian H Irwin3, Terry Mosher1, Mark T Hegel1.   

Abstract

Benefits of early diagnosis and treatment remain debatable for men with low-risk prostate cancer. Active surveillance (AS) is an alternative to treatment. The goal of AS is to identify patients whose cancer is progressing rapidly while avoiding treatment in the majority of patients. The purpose of this study was to explore cognitive and affective representations of AS within a clinical environment that promotes AS a viable option for men with low-risk prostate cancer. Participants included patients for whom AS and active treatment were equally viable options, as well as practitioners who were involved in consultations for prostate cancer. Data were generated from semistructured interviews and audits of consultation notes and were analyzed using thematic analysis. Nineteen patients and 16 practitioners completed a semistructured interview. Patients generally viewed AS as a temporary strategy that was largely equated with inaction. There was variation in the degree to which inaction was viewed as warranted or favorable. Patient perceptions of AS were generally malleable and able to be influenced by information from trusted sources. Encouraging slow deliberation and multiple consultations may facilitate greater understanding and acceptance of AS as a viable treatment option for low-risk prostate cancer.

Entities:  

Keywords:  active surveillance; choice behavior; decision making; prostatic neoplasm; qualitative research

Year:  2016        PMID: 27365211      PMCID: PMC5675168          DOI: 10.1177/1557988316657041

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  18 in total

Review 1.  Active surveillance for prostate cancer: for whom?

Authors:  Laurence Klotz
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

Review 2.  Integration of the cognitive and the psychodynamic unconscious.

Authors:  S Epstein
Journal:  Am Psychol       Date:  1994-08

3.  Men managing cancer: a gender analysis.

Authors:  Lisa M Wenger; John L Oliffe
Journal:  Sociol Health Illn       Date:  2013-08-20

4.  Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.

Authors:  M S Litwin; D J Pasta; J Yu; M L Stoddard; S C Flanders
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

5.  Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.

Authors:  Stijn Roemeling; Monique J Roobol; Stijn H de Vries; Tineke Wolters; Claartje Gosselaar; Geert J L H van Leenders; Fritz H Schröder
Journal:  Eur Urol       Date:  2006-12-05       Impact factor: 20.096

6.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

7.  Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment.

Authors:  Michael A Diefenbach; Nihal E Mohamed
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

8.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Authors:  Laurence Klotz; Liying Zhang; Adam Lam; Robert Nam; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Patient perspective on watchful waiting/active surveillance for localized prostate cancer.

Authors:  Jinping Xu; Anne Victoria Neale; Rhonda K Dailey; Susan Eggly; Kendra L Schwartz
Journal:  J Am Board Fam Med       Date:  2012 Nov-Dec       Impact factor: 2.657

10.  The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Authors:  Matthew R Cooperberg; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  4 in total

1.  Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Authors:  Richard M Hoffman; Tania Lobo; Stephen K Van Den Eeden; Kimberly M Davis; George Luta; Amethyst D Leimpeter; David Aaronson; David F Penson; Kathryn Taylor
Journal:  Med Decis Making       Date:  2019-10-21       Impact factor: 2.583

2.  Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

Authors:  Netty Kinsella; Pär Stattin; Declan Cahill; Christian Brown; Anna Bill-Axelson; Ola Bratt; Sigrid Carlsson; Mieke Van Hemelrijck
Journal:  Eur Urol       Date:  2018-03-26       Impact factor: 20.096

3.  Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.

Authors:  Emily M Mader; Hsin H Li; Kathleen D Lyons; Christopher P Morley; Margaret K Formica; Scott D Perrapato; Brian H Irwin; John D Seigne; Elias S Hyams; Terry Mosher; Mark T Hegel; Telisa M Stewart
Journal:  BMC Urol       Date:  2017-05-08       Impact factor: 2.264

Review 4.  Quality of life in active surveillance and the associations with decision-making-a literature review.

Authors:  Julia Menichetti; Riccardo Valdagni; Lara Bellardita
Journal:  Transl Androl Urol       Date:  2018-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.